Retour
Fourchette du Jour
13,62 €
13,66 €
Fourchette 52 Semaines
6,47 €
13,68 €
Volume
962 004
Moyenne 50J / 200J
11,93 €
/
9,24 €
Clôture Précédente
13,62 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -150,6 | 0,3 |
| P/B | 1,3 | 2,9 |
| ROE % | -0,9 | 3,7 |
| Net Margin % | -0,4 | 3,8 |
| Rev Growth 5Y % | -1,1 | 10,0 |
| D/E | 0,9 | 0,2 |
Objectif de Cours des Analystes
Hold
13,53 €
-1.0%
Low: 12,00 €
High: 14,00 €
P/E Prévisionnel
22,6
BPA Prévisionnel
0,60 €
Croissance BPA (est.)
+0,0%
CA Est.
1,1 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
0,30 €
0,30 € – 0,30 €
|
1,3 B | 1 |
| FY2028 |
0,62 €
0,50 € – 0,74 €
|
1,2 B | 2 |
| FY2027 |
0,64 €
0,61 € – 0,68 €
|
1,1 B | 3 |
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 |
Jolley Julie Diane
EVP of Home Health Operations
|
sell | 2 793 | 13,63 € | 38 069 € |
| Mar 9, 2026 |
Jolley Julie Diane
EVP of Home Health Operations
|
sell | 2 793 | 13,63 € | 38 069 € |
| Mar 7, 2026 |
Black Dylan C
General Counsel and Secretary
|
other | 2 422 | 13,61 € | 32 963 € |
| Mar 7, 2026 |
Solomon Ryan
Chief Financial Officer
|
other | 3 882 | 13,61 € | 52 834 € |
| Mar 6, 2026 |
Black Dylan C
General Counsel and Secretary
|
grant | 10 030 | 13,61 € | 136 508 € |
| Mar 6, 2026 |
Black Dylan C
General Counsel and Secretary
|
other | 3 747 | 13,61 € | 50 997 € |
| Mar 6, 2026 |
Solomon Ryan
Chief Financial Officer
|
grant | 12 859 | 13,61 € | 175 011 € |
| Mar 6, 2026 |
Solomon Ryan
Chief Financial Officer
|
other | 5 127 | 13,61 € | 69 778 € |
| Mar 6, 2026 |
Jolley Julie Diane
EVP of Home Health Operations
|
grant | 12 050 | 13,61 € | 164 001 € |
| Jan 10, 2026 |
Bolton Jeffrey
Director
|
grant | 3 761 | 9,97 € | 37 497 € |
| Jan 10, 2026 |
Rush Gregory S
Director
|
grant | 2 508 | 9,97 € | 25 005 € |
| Oct 10, 2025 |
Ohlendorf Mark W
Director
|
grant | 2 344 | 8,00 € | 18 752 € |
| Aug 5, 2025 |
Marion Tanya Renee
Chief Human Resources Officer
|
grant | 26 159 | 6,69 € | 175 004 € |
| Jul 10, 2025 |
Schochet Barry P.
Director
|
grant | 3 267 | 7,27 € | 23 751 € |
| Jul 10, 2025 |
Rush Gregory S
Director
|
grant | 3 439 | 7,27 € | 25 002 € |
| Jul 1, 2025 |
Marion Tanya Renee
Chief Human Resources Officer
|
other | 1 983 | 7,88 € | 15 626 € |
| Jul 1, 2025 |
Jolley Julie Diane
EVP of Home Health Operations
|
other | 3 032 | 7,88 € | 23 892 € |
| Jun 26, 2025 |
Bolton Jeffrey
Director
|
grant | 15 773 | 9,51 € | 150 001 € |
| Jun 26, 2025 |
Brown-Stevenson Tina L.
Director
|
grant | 15 773 | 9,51 € | 150 001 € |
| May 1, 2025 |
Abou-Oaf Ehab
Pres. Int'l Fam. Care & Prof.
|
other | 2 732 | — | — |
Points Clés
Revenue declined -1,07% annually over 5 years
Generating 65,80M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3,51%
Capital efficient — spends only 0,46% of revenue on capex
ROIC of 4,63% — low return on invested capital
Interest coverage of 1,88× — tight debt servicing
Croissance
Revenue Growth (5Y)
-1,07%
Revenue (1Y)2,44%
Earnings (1Y)N/A
FCF Growth (3Y)21,06%
Qualité
Return on Equity
-0,87%
ROIC4,63%
Net Margin-0,43%
Op. Margin6,02%
Sécurité
Debt / Equity
0,94
Current Ratio1,63
Interest Coverage1,88
Valorisation
P/E Ratio
-150,63
P/B Ratio1,30
EV/EBITDA18,01
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,44% | Revenue Growth (3Y) | 0,65% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -1,07% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,06B | Net Income (TTM) | -4,60M |
| ROE | -0,87% | ROA | -0,39% |
| Gross Margin | 46,92% | Operating Margin | 6,02% |
| Net Margin | -0,43% | Free Cash Flow (TTM) | 65,80M |
| ROIC | 4,63% | FCF Growth (3Y) | 21,06% |
| Safety | |||
| Debt / Equity | 0,94 | Current Ratio | 1,63 |
| Interest Coverage | 1,88 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -150,63 | P/B Ratio | 1,30 |
| P/S Ratio | 0,65 | PEG Ratio | 1,05 |
| EV/EBITDA | 18,01 | Dividend Yield | 0,00% |
| Market Cap | 692,88M | Enterprise Value | 1,15B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,06B | 1,03B | 1,05B | 1,07B | 1,11B |
| Net Income | -4,60M | -156,20M | -80,50M | -40,40M | 111,10M |
| EPS (Diluted) | -0,09 | -3,11 | -1,61 | 1,25 | 28,49 |
| Gross Profit | 497,30M | 504,00M | 510,70M | 545,50M | 592,70M |
| Operating Income | 63,80M | -115,10M | -47,60M | -11,40M | 142,90M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,17B | 1,23B | 1,43B | 1,53B | 1,72B |
| Total Liabilities | 603,00M | 672,10M | 731,90M | 751,50M | 236,70M |
| Shareholders' Equity | 534,00M | 523,50M | 669,70M | 741,70M | 1,47B |
| Total Debt | 500,00M | 569,50M | 610,10M | 625,20M | 56,90M |
| Cash & Equivalents | 43,60M | 28,40M | 27,40M | 22,90M | 5,40M |
| Current Assets | 205,60M | 192,70M | 210,10M | 211,80M | 178,80M |
| Current Liabilities | 126,30M | 126,20M | 137,70M | 132,90M | 136,50M |